NIH-funded research R03 grant

Using MRI to track immune cell behavior in organ transplant patients

Official title: Magnetic resonance imaging methods to track Treg distribution and homing for clinical applications

Funded at University of California, San Diego · NIH-11195514 · Data updated 2026-11-12

This study is looking at how MRI can help doctors see and track special immune cells called Tregs in patients who have received organ transplants, with the goal of finding better ways to prevent organ rejection and improve care for transplant recipients.

More Magnetic Resonance Imaging research and trials

Quick facts

Grant typeR03 grant
Study typeNIH-funded research
Funding institutionUniversity of California, San Diego
NIH-funded
Lab location1 site (La Jolla, United States)
Project startMarch 11, 2024
Project endFebruary 28, 2026
Funding year2025
Award (this year)$74,818
NIH project number5R03EB035177-02
Project IDNIH-11195514 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals who have received a solid organ transplant and are at risk of organ rejection.

Less likely to help

Patients who have not undergone organ transplantation or those who are not at risk of rejection may not benefit from this research.

What this research studies

This research investigates how magnetic resonance imaging (MRI) can be used to visualize the distribution and movement of regulatory T cells (Tregs) in patients who have undergone solid organ transplantation. By tracking these immune cells, the study aims to improve understanding of how Tregs can help prevent organ rejection, which is a common complication after transplant surgery. The approach focuses on developing imaging techniques that are safe and effective, allowing clinicians to monitor the effectiveness of Treg therapies in real-time. This could lead to better management of immunosuppression and improved outcomes for transplant recipients.

Why it matters

Potential benefit: If successful, this research could lead to more effective treatments for preventing organ rejection in transplant patients, enhancing their quality of life and survival rates.

How similar studies have gone: Previous research has shown promising results using imaging techniques to monitor immune responses, suggesting that this approach could be effective.

Where this research is happening

  • University of California, San Diego
    La Jolla, United States
    Active

Researchers

  • Principal investigator: Chapelin, Fanny — University of California, San Diego
  • Study coordinator: Chapelin, Fanny

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.